Discover
AEON
AEON Biopharma, Inc.
0.24
500 x undefined
600 x undefined
bid
ask
-
0.00
1.54%
550 @ 04:10 AM
0.24 +0.00 (0.00%)
| Ytd | -77.95% | |
| 1y | -68.09% |
0.24
day range
0.27
0.18
52 week range
1.45
| Open | 0.25 | Prev Close | 0.25 | Low | 0.24 | High | 0.27 | Mkt Cap | 12.10M |
| Vol | 2.08M | Avg Vol | 6.55M | EPS | -4.55 | P/E | N/A | Forward P/E | -0.84 |
| Beta | 0.40 | Short Ratio | 1.60 | Inst. Own | 33.14% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 0.27 | 200-d Avg | 0.78 | 1yr Est | 5.00 |
| Income Statement | |||
| Operating Expenses | 5.92M | ||
| Research and Development Expense | 2.94M | ||
| Selling, General and Administrative Expense | 2.99M | ||
| Operating Income | -5.92M | ||
| Net Income | -1.15M | ||
| Net Income Common Stock | -1.15M | ||
| Net Income Common Stock (USD) | -1.15M | ||
| Consolidated Income | -1.15M | ||
| Earnings per Basic Share | -0.02 | ||
| Earnings per Basic Share (USD) | -0.02 | ||
| Earnings per Diluted Share | -0.02 | ||
| Earning Before Interest & Taxes (EBIT) | -1.15M | ||
| Earning Before Interest & Taxes (USD) | -1.15M | ||
| Weighted Average Shares | 50.53M | ||
| Weighted Average Shares Diluted | 50.53M | ||
| Balance Sheet | |||
| Cash and Equivalents | 3.43M | ||
| Cash and Equivalents (USD) | 3.43M | ||
| Current Assets | 3.99M | ||
| Property, Plant & Equipment Net | 1.05M | ||
| Total Assets | 5.91M | ||
| Total Debt | 2.51M | ||
| Current Liabilities | 7.34M | ||
| Debt Non-Current | 2.51M | ||
| Total Liabilities | 21.27M | ||
| Accumulated Retained Earnings (Deficit) | -483.77M | ||
| Shareholders Equity | -15.36M | ||
| Shareholders Equity (USD) | -15.36M | ||
| Assets Non-Current | 1.92M | ||
| Total Debt (USD) | 2.51M | ||
| Liabilities Non-Current | 13.93M | ||
| Trade and Non-Trade Payables | 2.70M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 20.00K | ||
| Net Cash Flow from Financing | 886.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -2.81M | ||
| Issuance (Purchase) of Equity Shares | 886.00K | ||
| Net Cash Flow from Operations | -3.70M | ||
| Share Based Compensation | 1.66M | ||